Ohio Attorney General Dave Yost issued a warning to several Ohio medical spas over their alleged claims regarding weight-loss drugs.

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide offerings.

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Key Takeaways A pill to treat obesity caused liver injury in a clinical trialPfizer said it will stop developing the drug, called danuglipron, as a result Other alternatives to injectable obesity ...

Medications like Ozempic, Wegovy, and Zepbound have helped many Americans lose weight, but there are still some ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Mounjaro's launch of a weight-loss drug has sparked interest amongst the people of India despite the high price. Experts believe that making the drug locally available would help to reduce the black ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

A study found that medicines marketed as Zepbound and Mounjaro can help people lose weight for up to three years.